Skip to main content
BKYI
NASDAQ Technology

BIO-key to be Delisted from Nasdaq, Shares Move to OTC Markets

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Security & Protection Stocks · Industrial
Sentiment info
Negative
Importance info
9
Price
$3.23
Mkt Cap
$3.755M
52W Low
$3.4
52W High
$19.7
52W Position info
5.0% below low
Off High info
84% below high
Rel. Volume info
8.6× avg
Market data snapshot near publication time

BKYI is trading near its 52-week low of $3.4 (5.0% below the low) on elevated volume (8.6× avg).

Summary

BIO-key International announced its common stock will be suspended from Nasdaq and moved to OTC Markets due to non-compliance with bid price and annual report filing rules.


Key Events · Corporate Governance and Compliance · BKYI

  • Nasdaq Delisting Imminent

    Trading of BIO-key's common stock will be suspended from the Nasdaq Capital Market at the opening of business on May 13, 2026, with a Form 25-NSE to be filed for removal from listing and registration.

  • Dual Compliance Failures

    The delisting is due to the company's failure to regain compliance with Nasdaq's $1.00 minimum bid price rule and its failure to file the Annual Report on Form 10-K for the year ended December 31, 2025.

  • Transition to OTC Markets

    Effective with the opening of trading on May 13, 2026, the company's common stock will be traded on OTC Markets under the ticker symbol 'BKYI'.

  • Appeal Intended

    BIO-key intends to timely request a hearing before a Nasdaq Hearings Panel to appeal the delisting determination and seek to regain compliance.


Analysis · BKYI · Technology

BIO-key International's common stock will be suspended from Nasdaq and moved to the less liquid OTC Markets due to two critical compliance failures: not maintaining the $1.00 minimum bid price for the required period and failing to file its Annual Report on Form 10-K for 2025. This delisting, occurring while the stock trades near its 52-week low, significantly impacts the company's visibility and access to institutional capital, despite management's intent to appeal and positive business outlook.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BKYI was trading at $3.23 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.8M. The 52-week trading range was $3.40 to $19.70. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BKYI - Latest Insights

BKYI
Nov 13, 2026, 3:57 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.13
Real-time Price: $1.99 info
Change: -$0.140 (-7%) info
Market Cap: $4.07M info
BKYI
Nov 13, 2026, 7:59 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.68
Real-time Price: $1.99 info
Change: -$0.690 (-26%) info
Market Cap: $4.07M info
BKYI
Oct 30, 2026, 5:02 PM EDT
Filing Type: S-1/A
Importance Score:
7
Price at Filing: $2.69
Real-time Price: $1.99 info
Change: -$0.700 (-26%) info
Market Cap: $4.07M info
BKYI
Oct 09, 2026, 5:00 PM EDT
Filing Type: S-1
Importance Score:
7
Price at Filing: $1.60
Real-time Price: $1.99 info
Change: +$0.390 (+24%) info
Market Cap: $4.07M info
BKYI
Oct 02, 2026, 5:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.06
Real-time Price: $1.99 info
Change: -$0.070 (-3%) info
Market Cap: $4.07M info